Daniel Blumberger

Characteristics and period prevalence of self-induced disorder in patients referred to a pain clinic with the diagnosis of complex regional pain syndrome.

Biomarkers in geriatric psychiatry: searching for the holy grail?

Evidence of cortical inhibitory deficits in major depressive disorder.

Repetitive transcranial magnetic stimulation for refractory symptoms in schizophrenia.

Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.

Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.

A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.

MRI-targeted repetitive transcranial magnetic stimulation of Heschl's gyrus for refractory auditory hallucinations.

The role of transcranial magnetic stimulation in treatment-resistant depression: a review.

A randomized double-blind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression.

Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial.

Characteristics of older adults hospitalized in acute psychiatric units in ontario: a population-based study.

Transitional interventions to reduce early psychiatric readmissions in adults: systematic review.

Dynamic prediction of treatment response in late-life depression.

The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.

What is the role of brain stimulation therapies in the treatment of depression?

PAS-induced potentiation of cortical-evoked activity in the dorsolateral prefrontal cortex.

Repetitive transcranial magnetic stimulation to maintain treatment response to electroconvulsive therapy in depression: a case series.

Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression.

Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.

Systematic review of gamma-aminobutyric-acid inhibitory deficits across the reproductive life cycle.

Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.

What does the electroencephalogram tell us about the mechanisms of action of ECT in major depressive disorders?

Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies.

Magnetic seizure therapy-induced mania: a report of 2 cases.

A systematic approach to pharmacotherapy for geriatric major depression.

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.

Transcranial direct current stimulation (tDCS) for treatment of major depression during pregnancy: study protocol for a pilot randomized controlled trial.

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report.

rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation.

Clozapine potentiation of GABA mediated cortical inhibition in treatment resistant schizophrenia.

Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex.